
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Curing HIV: Seeking to Target and Clear Persistent Infection
David M. Margolis, Nancie M. Archin, Myron S. Cohen, et al.
Cell (2020) Vol. 181, Iss. 1, pp. 189-206
Open Access | Times Cited: 154
David M. Margolis, Nancie M. Archin, Myron S. Cohen, et al.
Cell (2020) Vol. 181, Iss. 1, pp. 189-206
Open Access | Times Cited: 154
Showing 1-25 of 154 citing articles:
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
Steven G. Deeks, Nancie M. Archin, Paula M. Cannon, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2085-2098
Open Access | Times Cited: 254
Steven G. Deeks, Nancie M. Archin, Paula M. Cannon, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2085-2098
Open Access | Times Cited: 254
Carbohydrate-based drugs launched during 2000−2021
Xin Cao, Xiaojing Du, Heng Jiao, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 10, pp. 3783-3821
Open Access | Times Cited: 150
Xin Cao, Xiaojing Du, Heng Jiao, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 10, pp. 3783-3821
Open Access | Times Cited: 150
Update and latest advances in antiretroviral therapy
Luis Menéndez‐Arias, Rafaël Delgado
Trends in Pharmacological Sciences (2021) Vol. 43, Iss. 1, pp. 16-29
Open Access | Times Cited: 144
Luis Menéndez‐Arias, Rafaël Delgado
Trends in Pharmacological Sciences (2021) Vol. 43, Iss. 1, pp. 16-29
Open Access | Times Cited: 144
Combination anti-HIV antibodies provide sustained virological suppression
Michael C. Sneller, Jana Blažková, J. Shawn Justement, et al.
Nature (2022) Vol. 606, Iss. 7913, pp. 375-381
Open Access | Times Cited: 119
Michael C. Sneller, Jana Blažková, J. Shawn Justement, et al.
Nature (2022) Vol. 606, Iss. 7913, pp. 375-381
Open Access | Times Cited: 119
Discovery of a large-scale, cell-state-responsive allosteric switch in the 7SK RNA using DANCE-MaP
Samuel W. Olson, Anne‐Marie W. Turner, J. Winston Arney, et al.
Molecular Cell (2022) Vol. 82, Iss. 9, pp. 1708-1723.e10
Open Access | Times Cited: 81
Samuel W. Olson, Anne‐Marie W. Turner, J. Winston Arney, et al.
Molecular Cell (2022) Vol. 82, Iss. 9, pp. 1708-1723.e10
Open Access | Times Cited: 81
Examining Chronic Inflammation, Immune Metabolism, and T Cell Dysfunction in HIV Infection
Wenli Mu, Vaibhavi Patankar, Scott G. Kitchen, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 219-219
Open Access | Times Cited: 23
Wenli Mu, Vaibhavi Patankar, Scott G. Kitchen, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 219-219
Open Access | Times Cited: 23
AHR signaling is induced by infection with coronaviruses
Federico Giovannoni, Zhaorong Li, Federico Remes-Lenicov, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 67
Federico Giovannoni, Zhaorong Li, Federico Remes-Lenicov, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 67
Contemporary Medicinal Chemistry Strategies for the Discovery and Development of Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors
Zhao Wang, Srinivasulu Cherukupalli, Minghui Xie, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 5, pp. 3729-3757
Open Access | Times Cited: 50
Zhao Wang, Srinivasulu Cherukupalli, Minghui Xie, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 5, pp. 3729-3757
Open Access | Times Cited: 50
HIV infection of non-classical cells in the brain
Angela Wahl, Lena Al‐Harthi
Retrovirology (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 35
Angela Wahl, Lena Al‐Harthi
Retrovirology (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 35
A modular CRISPR screen identifies individual and combination pathways contributing to HIV-1 latency
Emily Hsieh, Derek H. Janssens, Patrick J. Paddison, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 1, pp. e1011101-e1011101
Open Access | Times Cited: 23
Emily Hsieh, Derek H. Janssens, Patrick J. Paddison, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 1, pp. e1011101-e1011101
Open Access | Times Cited: 23
Longitudinal Dynamics of Intact HIV Proviral DNA and Outgrowth Virus Frequencies in a Cohort of Individuals Receiving Antiretroviral Therapy
Shane D. Falcinelli, Kayla W. Kilpatrick, Jenna Read, et al.
The Journal of Infectious Diseases (2020)
Open Access | Times Cited: 67
Shane D. Falcinelli, Kayla W. Kilpatrick, Jenna Read, et al.
The Journal of Infectious Diseases (2020)
Open Access | Times Cited: 67
Genome-wide CRISPR knockout screen identifies ZNF304 as a silencer of HIV transcription that promotes viral latency
Simona Krasnopolsky, Alona Kuzmina, Ran Taube
PLoS Pathogens (2020) Vol. 16, Iss. 9, pp. e1008834-e1008834
Open Access | Times Cited: 55
Simona Krasnopolsky, Alona Kuzmina, Ran Taube
PLoS Pathogens (2020) Vol. 16, Iss. 9, pp. e1008834-e1008834
Open Access | Times Cited: 55
Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoir
Shringar Rao, Cynthia Lungu, Raquel Crespo, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 46
Shringar Rao, Cynthia Lungu, Raquel Crespo, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 46
HIV persistence: silence or resistance?
Alexander Pasternak, Ben Berkhout
Current Opinion in Virology (2023) Vol. 59, pp. 101301-101301
Open Access | Times Cited: 21
Alexander Pasternak, Ben Berkhout
Current Opinion in Virology (2023) Vol. 59, pp. 101301-101301
Open Access | Times Cited: 21
Impact of misclassified defective proviruses on HIV reservoir measurements
Daniel B. Reeves, Christian Gaebler, Thiago Y. Oliveira, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Daniel B. Reeves, Christian Gaebler, Thiago Y. Oliveira, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
A histone deacetylase network regulates epigenetic reprogramming and viral silencing in HIV-infected cells
Jackson J. Peterson, Catherine A. Lewis, Samuel D. Burgos, et al.
Cell chemical biology (2023) Vol. 30, Iss. 12, pp. 1617-1633.e9
Open Access | Times Cited: 18
Jackson J. Peterson, Catherine A. Lewis, Samuel D. Burgos, et al.
Cell chemical biology (2023) Vol. 30, Iss. 12, pp. 1617-1633.e9
Open Access | Times Cited: 18
Drug design targeting active posttranslational modification protein isoforms
Fanwang Meng, Zhongjie Liang, Kehao Zhao, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 3, pp. 1701-1750
Closed Access | Times Cited: 43
Fanwang Meng, Zhongjie Liang, Kehao Zhao, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 3, pp. 1701-1750
Closed Access | Times Cited: 43
HIV-1 Proviral Transcription and Latency in the New Era
Ashutosh Shukla, Nora-Guadalupe P. Ramirez, Iván D’Orso
Viruses (2020) Vol. 12, Iss. 5, pp. 555-555
Open Access | Times Cited: 40
Ashutosh Shukla, Nora-Guadalupe P. Ramirez, Iván D’Orso
Viruses (2020) Vol. 12, Iss. 5, pp. 555-555
Open Access | Times Cited: 40
Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy
Jana Blažková, Feng Gao, Manukumar Honnayakanahalli Marichannegowda, et al.
Nature Medicine (2021) Vol. 27, Iss. 11, pp. 1893-1898
Closed Access | Times Cited: 38
Jana Blažková, Feng Gao, Manukumar Honnayakanahalli Marichannegowda, et al.
Nature Medicine (2021) Vol. 27, Iss. 11, pp. 1893-1898
Closed Access | Times Cited: 38
Combined noncanonical NF-κB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivo
Shane D. Falcinelli, Jackson J. Peterson, Anne‐Marie W. Turner, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 8
Open Access | Times Cited: 28
Shane D. Falcinelli, Jackson J. Peterson, Anne‐Marie W. Turner, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 8
Open Access | Times Cited: 28
An ordeal that does not heal: understanding barriers to a cure for HIV-1 infection
Mathias Lichterfeld, Ce Gao, Xu G. Yu
Trends in Immunology (2022) Vol. 43, Iss. 8, pp. 608-616
Open Access | Times Cited: 25
Mathias Lichterfeld, Ce Gao, Xu G. Yu
Trends in Immunology (2022) Vol. 43, Iss. 8, pp. 608-616
Open Access | Times Cited: 25
BET Degraders Reveal BRD4 Disruption of 7SK and P-TEFb is Critical for Effective Reactivation of Latent HIV in CD4+ T-cells
Anne‐Marie W. Turner, Frances M. Bashore, Shane D. Falcinelli, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Anne‐Marie W. Turner, Frances M. Bashore, Shane D. Falcinelli, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Persistent HIV-1 transcription during ART: time to reassess its significance?
Céline Fombellida-Lopez, Ben Berkhout, Gilles Darcis, et al.
Current Opinion in HIV and AIDS (2024) Vol. 19, Iss. 3, pp. 124-132
Open Access | Times Cited: 5
Céline Fombellida-Lopez, Ben Berkhout, Gilles Darcis, et al.
Current Opinion in HIV and AIDS (2024) Vol. 19, Iss. 3, pp. 124-132
Open Access | Times Cited: 5
SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus Macaques
Amir Dashti, Chevaughn Waller, Maud Mavigner, et al.
Journal of Virology (2020) Vol. 94, Iss. 21
Open Access | Times Cited: 33
Amir Dashti, Chevaughn Waller, Maud Mavigner, et al.
Journal of Virology (2020) Vol. 94, Iss. 21
Open Access | Times Cited: 33
Forging a Functional Cure for HIV: Transcription Regulators and Inhibitors
Sonia Mediouni, Shuang Lyu, Susan M. Schader, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 1980-1980
Open Access | Times Cited: 19
Sonia Mediouni, Shuang Lyu, Susan M. Schader, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 1980-1980
Open Access | Times Cited: 19